President's page: The promise of prevention: So, why aren't all cardiologists preventive?

Journal of the American College of Cardiology

Volumn 44, Issue 10, 2004, Pages 2082-2084

  Wolk, Michael J ^a   Bairey Merz, C Noel ^a   Thompson, Paul D ^a  

^a New York 10021 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE CONTROL; DISEASE COURSE; DISEASE PREDISPOSITION; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; LIFESTYLE; MEDICAL PRACTICE; MEDICAL SPECIALIST; NUTRITIONAL SUPPORT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION; SMOKING CESSATION;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOLOGY; CARDIOVASCULAR DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PHYSICIAN'S PRACTICE PATTERNS; PLATELET AGGREGATION INHIBITORS; UNITED STATES;

EID: 8144230556     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.10.017     Document Type: Conference Paper

References (18)

1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. Heart Protection Study Collaborative Group MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
3. S.M. Grundy, J.I. Cleeman, C.N Bairey Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
4. Antiplatelet Trialist's Collaboration Secondary prevention of vascular disease by prolonged antiplatelet treatment BMJ 296 1983 320 331
5. R.S. Eidelman, P.R. Hebert, S.M. Weisman, C.H. Hennekins An update on aspirin in the primary prevention of cardiovascular disease Arch Intern Med 163 2003 2006 2010
6. L. Annemans, A. Dresse, X. Kurz An acetylsalicylic acid-dipyridamole combination (Asasantine) in the prevention of the recurrence of cerebrovascular accidents (a cost-effectiveness analysis) Rev Med Liege 53 1998 265 269
7. The Beta-Blocker Pooling Project Research Group The Beta-Blockers Pooling Project (BBPP): subgroup findings from randomized trials in post infarction patients Eur Heart J 9 1988 8 16
8. S.C. Smith Jr., S.N. Blair, M.H Criqui AHA consensus panel statement Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel J Am Coll Cardiol 26 1995 292 294
9. National High Blood Pressure Education Program The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JAMA 289 2003 2560 2572
10. S.C. Smith Jr., S.N. Blair, M.H Criqui Preventing heart attack and death in patients with coronary disease Endorsed by the board of trustees of the American College of Cardiology Cardiovasc Nurs 32 1996 26 28
11. C. Wilhemsson, D. Elmfeldt, J.A. Vedin, G. Tibblin Smoking and myocardial infarction Lancet i 1975 415 419
12. M. Lorgeril, S. Renaud, M Nicole Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease Lancet 343 1994 1454 1459
13. G.T. O'Connor, J.E. Buring, S Yusuf An overview of randomized trials of rehabilitation with exercise after myocardial infarction Circulation 80 1989 234 244
14. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
15. Gordon NF, English CD, Contractor AS, et al. Effectiveness of three models for comprehensive cardiovascular disease risk reduction. Am J Cardiol 2002;89:1263-8
16. D. Mukerjee, J. Fang, S Chetcuti Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation 109 2004 745 749
17. S.V. Rao, P. Kaul, L.K Newby Poverty, process of care and outcome in acute coronary syndromes J Am Coll Cardiol 41 2003 1948 1954
18. C.N. Bairey Merz, G.A. Mensah, V. Fuster, P. Greenland, P.D. Thompson Task force #5--the role of cardiovascular specialists as leaders in prevention: from training to champion. 33rd Bethesda Conference: Preventive Cardiology: How Can We Do Better? J Am Coll Cardiol 40 2002 579 651